Complementary information to the article: recommendations for management and follow-up in patients with transthyretin-mediated hereditary amyloidosis

Gina González-RobledoSandra Milena Castellar-LeonesAndrés Díaz-CamposJorge Arturo Díaz RuízJennifer GarayGermán C. Giraldo-GonzálezMartha Gómez-CastroJuan David López‐Pónce de LeónErika M. Martínez-CarreñoJairo H. Naranjo-Flóres2026-03-222026-03-22202410.24875/rccare.m24000089https://doi.org/10.24875/rccare.m24000089https://andeanlibrary.org/handle/123456789/75163enTransthyretinAmyloidosisMedicineIntensive care medicineComplementary information to the article: recommendations for management and follow-up in patients with transthyretin-mediated hereditary amyloidosisarticle